Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis.
about
Psychological interventions for multiple sclerosisPsychological interventions for multiple sclerosisEvidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of NeurologyDepressogenic effects of medications: a reviewThe challenge of comorbidity in clinical trials for multiple sclerosisSymptomatic management in multiple sclerosisPsychopathology in multiple sclerosis: diagnosis, prevalence and treatmentThe Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platformAdherence to interferon β-1b treatment in patients with multiple sclerosis in SpainCritical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adultsReview of intervention studies on depression in persons with multiple sclerosis.Recent developments in drug therapy for multiple sclerosis.Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence.Multiple sclerosis in First Nations Canadians: A pilot comparison study.Depression, medication adherence, and service utilization in systemic lupus erythematosusMultiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided QualityMultiple sclerosis: empirical literature for the clinical health psychologist.Mood disorders associated with interferon treatment: theoretical and practical considerations.Comorbid anxiety disorders and treatment of depression in people with multiple sclerosisInternet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.The safety and efficacy of IFN-beta products for the treatment of multiple sclerosis.Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors.Exercise and the treatment of clinical depression in adults: recent findings and future directions.Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort studyUse of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study.Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.Comorbidity increases the risk of hospitalizations in multiple sclerosis.Pain affects depression through anxiety, fatigue, and sleep in multiple sclerosis.Walgreens connected care: impact of managed therapy on adherence to medications used to treat multiple sclerosis and related comorbid conditions.Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis.Depression in epilepsy: ignoring clinical expression of neuronal network dysfunction?Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis.Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional StudyThe assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studies.The Goldman Consensus statement on depression in multiple sclerosis.Differences in the burden of psychiatric comorbidity in MS vs the general population.Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.
P2860
Q24244909-3033D870-43E9-4450-9ACF-15020881A0B1Q24247870-D5FDF0BD-46C2-4F78-8AFF-8C81228430CDQ24615757-AA688776-4201-489F-BB2C-A1307171DB73Q24635465-85586D73-BE05-4485-996D-245C38768DBEQ26765031-709D4CFD-0862-48A6-AC82-771075D97897Q26779897-D5277879-B382-46DE-8BC2-7CCF57F8F442Q28301691-FD776D2F-AAB7-4980-83FB-E2C26AFCC369Q28488248-E3FBC179-5132-489E-AF83-F84941D44718Q28729921-B0D8542A-AE2F-4631-B4D8-2516E0AED174Q28764080-B79CE0C4-D05A-4E53-96A8-F0C385F4345BQ30542657-F8B338D4-7B2D-48A6-864D-18D9804CA84AQ33639891-0CB0859F-2BA2-417E-BBE5-70375518917DQ33644812-17DECD72-3D13-48F7-AC34-5260661C0D1DQ33692742-38EF4B88-415F-4AFD-BD62-1A7DD9999F7BQ33871960-87281742-29D2-411E-984D-58B5154BE9E0Q34152800-6F7FD374-860B-4661-A3EF-79AAEE3C3A0DQ34187515-2A26148C-CF18-44AC-96B5-602AC95ECC03Q34219107-57B06133-78C7-4929-A6EE-906E931DE076Q34330330-A933D979-9AEF-4025-BC09-C6D620FEC51CQ34411269-7243FC13-2C04-45B4-8A48-4AD612DDCAD8Q34457934-661C1465-C1A9-4ED9-9273-882EF62E188AQ34578783-341CF87A-191B-4413-B81D-B98025484783Q34579232-4C92F3B8-3278-43E1-8ABF-008CFC86EA20Q34743215-6FBBEFC0-2FA7-4EE3-9EA6-E64F5F134F43Q34868966-DA625C81-4333-4BA6-8D88-F148BB4B8EFFQ34980458-0967B287-9E8B-4BBB-8DB1-6BEA94CC7589Q35001445-19CFCC17-2C98-49B2-9F66-1D9CA531B41AQ35018491-39B73F66-6C18-41AE-B3DB-757642AC0745Q35065539-D730BA68-44DA-4D91-B43F-8E96EAADE628Q35106304-DF15E929-A9D6-4B23-B100-33B349834074Q35146090-9B2E6C64-1D1A-4E9D-8480-34111D29B5CFQ35446515-6B0CBBBA-E07B-4CC4-8F7A-73710356DF3CQ35557398-4A72378B-3EC1-4AE6-BEAE-B035ED7E056AQ35798244-B56FBE53-01FF-4BCF-9A31-18EE6E074501Q35844748-AC7C9080-21CC-40F7-963B-DC79B128BB9EQ35882486-4F561128-5FD0-4CBC-B9BA-FD6A426835A2Q36095314-9829F045-3104-4C43-A783-968497D6EDF3Q36163778-5822063D-78AA-4FA7-B386-49A5A268A1D6Q36331451-911F311F-D922-4A94-83CE-DE880479FA50Q36337359-5246AE9A-AD5B-422C-A20B-F22A141C565F
P2860
Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Treatment of depression improv ...... herapy for multiple sclerosis.
@en
Treatment of depression improv ...... herapy for multiple sclerosis.
@nl
type
label
Treatment of depression improv ...... herapy for multiple sclerosis.
@en
Treatment of depression improv ...... herapy for multiple sclerosis.
@nl
prefLabel
Treatment of depression improv ...... herapy for multiple sclerosis.
@en
Treatment of depression improv ...... herapy for multiple sclerosis.
@nl
P2093
P1433
P1476
Treatment of depression improv ...... herapy for multiple sclerosis.
@en
P2093
P304
P356
10.1001/ARCHNEUR.1997.00550170015009
P577
1997-05-01T00:00:00Z